IP Verse

Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs - EP3411402

PATENT ANALYSIS

Patent Details

Grant Date
Dec 22, 2021
Company
AMGEN INC.
Oppositions

STRAWMAN LIMITED

More patents of Amgen Inc.

EP4058148

EP2301961

EP2445924

Want to monitor this patent?

Feel free to send us a message here and we will get back to you